TARA LINVILLE: Open Payments
NPI 1013994458 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,639 in 301 payments from 19 companies in 2025. Trend: 2023 $4,475 · 2024 $5,006 · 2025 $6,639
Food & beverage: $6,533Education: $107
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $779 |
| PFIZER INC. | 35 | $773 |
| ABBVIE INC. | 24 | $681 |
| Amgen Inc. | 20 | $533 |
| UCB, Inc. | 40 | $530 |
| Regeneron Healthcare Solutions, Inc. | 16 | $523 |
| Arcutis Biotherapeutics, Inc. | 26 | $522 |
| Novartis Pharmaceuticals Corporation | 23 | $486 |
| Lilly USA, LLC | 15 | $378 |
| E.R. Squibb & Sons, L.L.C. | 19 | $284 |
Products named: TREMFYA, CIBINQO, DUPIXENT, Otezla, Zoryve, Bimzelx, RINVOQ, COSENTYX.
Industry payments across OK — which companies pay providers there.
